CPT code 25065 represents an excisional biopsy of suspicious superficial soft tissue in the forearm or wrist submitted for laboratory pathology. The code captures a common diagnostic surgical service that guides definitive diagnosis and subsequent treatment decisions for soft-tissue masses or lesions. Nationally, accurate coding for biopsies like 25065 affects clinical documentation, coverage determinations, and claims adjudication across public and commercial payers.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and the procedural intent behind the code. The publication provides benchmarks where available, highlights relevant billing and policy considerations affecting reimbursement and claim processing, and outlines how documentation supports medical necessity for pathology-directed procedures.

This summary is designed for clinicians, billing professionals, and policy analysts seeking clarity on when CPT code 25065 applies, how it is used in clinical workflows, and what to expect from payer coverage and administrative processes at a national level.